S. S. H. Davarani et al. / Tetrahedron Letters 49 (2008) 710–714
713
area) and a large surface platinum gauze constituted the
2.1.3. 6-Amino-5-(3,4-dihydroxy-5-methoxyphenyl)
counter electrode (graphite rods from Azar Electrode,
Urmieh, Iran and all other electrodes from Metrohm).
The working electrode potentials were measured versus
3 M Ag/AgCl.
3-Methyl catechol was reagent grade material from
Acros. All other chemicals were reagent or pro-analysis
grade materials from Merck. These chemicals were used
without any further purification.
pyrimidine-2,4(1H,3H)-dione (5c, C11H11N3O5)
Mp >270 °C; IR (KBr) (mmax cmꢀ1): 3401, 1698, 1621,
1596, 1512, 1392, 1207, 1085. 1H NMR (300 MHz
DMSO-d6): d 3.70 (s, 3H, methoxy), 5.61 (s, 2H, NH2),
6.25 (s, 1H, aromatic), 6.28 (s, 1H, aromatic), 8.14 (s,
1H, OH), 8.79 (s, 1H, OH), 10.03 (s, 1H, NH), 10.32 (s,
1H, NH). 13C NMR (75.4 MHz DMSO-d6): d 56.09,
88.75, 106.76, 112.52, 122.92, 133.29, 145.94, 148.51,
150.44, 151.86, 163.49. Anal. Calcd for C11H11N3O5
(265.222): C, 49.81; H, 4.18; N, 15.84. Found: C, 49.77;
H, 4.15; N, 15.79. MS, m/z (%): 265 (M+, 100), 249 (15),
221 (5), 205 (25), 177 (20), 151 (10), 84 (15), 43 (89).
2.1. General procedure for the electro-organic synthesis of
5a–f
Sodium acetate (100 ml of 0.2 M) solution was pre elec-
trolyzed at the chosen potential (see Table 1) in a two-com-
partment cell. Next, 2 mmol of catechol 1a–c and
nucleophile 3a, 3b were added to the cell. Initially the cur-
rent density was 2 mA/cm2 and the electrolysis was termi-
nated when the decay of the current became more than
95%. The process was interrupted during electrolysis (due
to the formation of a thin film of product at the surface
of the electrode) and the graphite anode was washed in ace-
tone and polished to reactivate it. At the end of electrolysis,
a few drops of acetic acid were added to the solution and
the cell was placed in a refrigerator overnight. The precip-
itated solid was collected by filtration and after washing
with hot water and drying, the solid products were charac-
terized by IR, 1H NMR, 13C NMR, elemental analysis, and
MS.
2.1.4. 6-Amino-5-(3,4-dihydroxyphenyl)-1,3-dimethyl-
pyrimidine-2,4(1H,3H)-dione (5d, C12H13N3O4)
Mp >270 °C; IR (KBr) (mmax cmꢀ1): 3435, 3334, 3232,
1
1696, 1641, 1585, 1381, 1272, 1088, 780, 730. H NMR
(300 MHz DMSO-d6): d 3.12 (s, 3H, methyl), 3.32 (s, 3H,
methyl), 6.03 (s, 2H, NH2), 6.44 (d, J = 8 Hz, 1H, aro-
matic), 6.58 (s, 1H, aromatic), 6.72 (d, J = 8 Hz, 1H, aro-
matic) 8.81 (s, 1H, OH), 8.84 (s, 1H, OH). 13C NMR
(75.4 MHz DMSO-d6): d 28.05, 30.45, 89.30, 116.13,
119.50, 122.81, 124.78, 144.62, 145.55, 151.35, 152.24,
161.08. Anal. Calcd for C12H13N3O4 (263.249): C, 54.75;
H, 4.98; N, 15.96. Found: C, 54.81; H, 5.02; N, 15.99.
MS, m/z (%): 263 (M+, 100), 206 (25), 189 (25), 150 (60),
122 (25), 81 (10), 58 (75).
2.1.5. 6-Amino-5-(3,4-dihydroxy-5-methylphenyl)-1,3-
dimethylpyrimidine-2,4(1H,3H)-dione (5e, C13H15N3O4)
Mp >270 °C; IR (KBr) (mmax cmꢀ1): 3476, 3416, 1693,
1648, 1596, 1314, 1200, 1017, 771, 608. 1H NMR
(300 MHz DMSO-d6): d 2.10 (s, 3H, methyl), 3.12 (s, 3H,
methyl), 3.37 (s, 3H, methyl), 6.02 (s, 2H, NH2), 6.36 (s,
1H, aromatic), 6.46 (s, 1H, aromatic), 8.12 (s, 1H, OH),
9.10 (s, 1H, OH). 13C NMR (75.4 MHz DMSO-d6): d
16.0, 27.5, 29.9, 89.03, 116.2, 123.4, 124.1, 142.2, 144.6,
150.8, 151.7, 160.5. Anal. Calcd for C13H15N3O4
(277.27): C, 56.31; H, 5.45; N, 15.15. Found: C, 56.29; H,
5.45; N, 15.17. MS, m/z (%): 277 (M+, 100), 220 (25),
203 (25), 191 (25), 164 (50), 136 (50), 77 (20), 57 (70), 30
(30).
2.1.1. 6-Amino-5-(3,4-dihydroxyphenyl)pyrimidine-
2,4(1H,3H)-dione (5a, C10H9N3O4)
Mp >270 °C; IR (KBr) (mmax cmꢀ1): 3496, 3441, 3248,
2882, 1724, 1592, 1550, 1446, 1372, 1113, 772, 708. 1H
NMR (300 MHz DMSO-d6): d 5.57 (s, 2H, NH2), 6.45
(d, J = 6 Hz, 1H, aromatic), 6.61 (s, 1H, aromatic), 6.70
(d, J = 6 Hz, 1H, aromatic), 8.78 (s, 1H, OH), 8.82 (s,
1H, OH), 10.07(s, 1H, NH), 10.33 (s, 1H, NH). 13C
NMR (75.4 MHz DMSO-d6): d 115, 119, 122, 123, 144,
145, 150, 151, 163. Anal. Calcd for C10H9N3O4 (235.196):
C, 51.07; H, 3.68; N, 17.87. Found: C, 51.18; H, 3.74; N,
17.89. MS, m/z (%): 235 (M+, 100), 189 (10), 147 (25),
122 (10), 103 (10), 63 (20), 43 (90).
2.1.2. 6-Amino–5-(3,4-dihydroxy-5-methylphenyl)-
pyrimidine-2,4(1H,3H)-dione (5b, C11H11N3O4)
2.1.6. 6-Amino-5-(3,4-dihydroxy-5-methoxyphenyl)-1,3-
dimethylpyrimidine-2,4(1H,3H)-dione (5f, C13H15N3O5)
Mp >270 °C; IR (KBr) (mmax cmꢀ1): 3419, 3336, 3248,
1693, 1638, 1587, 1519, 1332, 1213, 1095, 1031, 849, 778,
674. 1H NMR (300 MHz DMSO-d6): d 3.33 (s, 3H,
methyl), 3.38 (s, 3H, methyl), 3.70 (s, 3H, methoxy), 6.08
(s, 2H, NH2), 6.25 (s, 1H, aromatic), 6.26 (s, 1H, aromatic),
8.19 (s, 1H, OH), 8.82 (s, 1H, OH). 13C NMR (75.4 MHz
DMSO-d6): d 28.05, 30.44, 56.09, 89.66, 107.15, 112.81,
123.85, 133.56, 146.13, 148.78, 151.36, 152.26, 161.00.
Anal. Calcd for C13H15N3O5 (293.27): C, 53.24; H, 5.15;
N, 14.33. Found: C, 53.29; H, 5.18; N, 14.35. MS, m/z
Mp >270 °C; IR (KBr) (mmax cmꢀ1): 3458, 3353, 1721,
1634, 1389, 1579, 1313, 972, 752, 672, 592. 1H NMR
(300 MHz DMSO-d6): d 2.09 (s, 3H, methyl), 5.54 (s, 2H,
NH2), 6.36 (s, 1H, aromatic), 6.47 (s, 1H, aromatic), 8.09
(s, 1H, OH), 9.08 (s, 1H, OH), 10.02 (s, 1H, NH), 10.30
(s, 1H, NH). 13C NMR (75.4 MHz DMSO-d6): d 16.1,
88.63, 116.45, 123.01, 124.24, 124.44, 142.45, 144.93,
150.45, 151.81, 163.58. Anal. Calcd for C11H11N3O4
(249.223): C, 53.01; H, 4.45; N, 16.86. Found: C, 53.07;
H, 4.42; N, 16.91. MS, m/z (%): 249 (M+, 100), 231 (45),
205 (45), 188 (25), 163 (50), 117 (20), 77 (25), 43 (91).